DNA stock news today

Ginkgo Bioworks posts Q3 2026 results and completes first autonomous lab sale

Ginkgo Bioworks released its third-quarter 2026 financial results. The company also said it made its first sale of an autonomous lab.

Ginkgo Bioworks posts smaller quarterly loss than expected, revenue tops forecast

The company's third-quarter loss per share came in narrower than analysts had projected. Revenue for the period also exceeded the consensus estimate.

Catherine Cifuentes-Rojas, board member at Ginkgo Bioworks, commits to reverse mentorship

A person serving on the board of Ginkgo Bioworks, Catherine Cifuentes-Rojas, has pledged to take part in reverse mentorship. No other details about the arrangement were provided.

Ginkgo Bioworks sets November 5 date for third-quarter 2026 results

The company will report how it performed in the third quarter of 2026 on November 5. Its quarterly results will be discussed that day.

Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.

TD Cowen keeps Hold rating on Ginkgo Bioworks, lifts target to $11

TD Cowen reiterated a Hold rating on Ginkgo Bioworks Holdings while raising its price target to $11. The update reflects the firm's latest view on the stock.

Ginkgo Bioworks joins $1.5B NSF X-Labs science program

Ginkgo Bioworks will give researchers in the NSF X-Labs program remote use of its automated laboratories and will run protein tests for their teams. The science program is worth $1.5 billion.

Ginkgo Bioworks to add Araceli's Endeavor imager to its Nebula lab

Ginkgo Bioworks plans to bring Araceli Biosciences' Endeavor device, which captures detailed cell images, into Nebula, its self-operating laboratory. The tool becomes part of that automated setup.

BTIG Reiterates Sell Rating on Ginkgo Bioworks, Keeps $5 Price Target

BTIG repeated its sell rating on Ginkgo Bioworks Holdings and left its $5 price target unchanged. The call restates the firm's existing negative view on the stock.

What is the latest news on DNA?

Nov 5, 2026: Ginkgo Bioworks posts Q3 2026 results and completes first autonomous lab sale (Fiscal.ai) · Nov 5, 2026: Ginkgo Bioworks posts smaller quarterly loss than expected, revenue tops forecast (Benzinga) · Oct 30, 2026: Catherine Cifuentes-Rojas, board member at Ginkgo Bioworks, commits to reverse mentorship (Fiscal.ai)

What has DNA filed with the SEC recently?

Oct 21, 2026: Ginkgo Bioworks Holdings, Inc. filed an insider trading report (Form 4)